BioSpace News Archive

Business

Neogen announced today that Dr. Daniel Kephart, formerly CSO, has resigned from the company to pursue alternative opportunities.

October 31, 2017

·

1 min read

BioCapital

IBBR and Frederick National Lab Establish a HPV Vaccine Development Collaboration

IBBR Research Fellow Dr. Alexander Andrianov and the Frederick National Lab’s Dr. Jason Marshall, will explore the ability of polyphosphazene immunoadjuvants to enhance the stability and immunogenicity of new vaccine candidates against HPV .

October 31, 2017

·

3 min read

Business

Cyrano Announces China Partnership and Associated Financing

Cyrano will establish a subsidiary in China, Wenzhou Cyrano, and NSB will provide regulatory, clinical and market development support to Wenzhou Cyrano to bring its intranasal formulation through the CFDA approval pathway and to patients throughout the country.

October 31, 2017

·

2 min read

Pharm Country

Celgene Announces Offering of Senior Unsecured Notes Under A Shelf Registration Statement

The interest rate, the maturity dates and other key terms of the offering are to be determined at the time of pricing.

October 31, 2017

·

3 min read

Biotech Beach

International Stem Cell Corporation Receives Key Stem Cell Patent in Australia

International Stem Cell Corporation announces ISCO’s patent covering methods for generating HLA homozygous parthenogenetic human stem cell lines from unfertilized eggs has been issued in Australia.

October 31, 2017

·

3 min read

BioForest

LumiThera Closes Series B Round of Financing

LumiThera raised $5.5M to support further development of its LT-300 device for the treatment for dry Age-related Macular Degeneration.

October 31, 2017

·

2 min read

Lombard Medical Reports First Half and Third Quarter 2017 Financial Results

During 2017, Lombard has refocused sales and marketing activities to concentrate on markets that yield the most revenue potential at a reasonable sales cost.

October 31, 2017

·

6 min read

Drug Development

Samumed Initiates Phase Ib Trial of SM04755 for Treatment of Psoriasis

Top-line data is expected by Q2 2018.

October 31, 2017

·

2 min read

Business

Minerva Neurosciences Names Dr. Justine Lalonde as Senior Vice President, Product Strategy

Dr. Lalonde was previously Medical Director, Neurosciences for Roche France in Paris.

October 31, 2017

·

4 min read

Drug Development

Forge Therapeutics and Collaborators From Evotec and USC Present New Efficacy Data At 2017 Keystone Symposia Conference

Forge announced new efficacy data today on Forge’s LpxC antibiotic program at the 2017 Keystone Symposia Conference “Antimicrobials and Resistance: Opportunities and Challenges” during an oral presentation and a poster session.

October 31, 2017

·

4 min read